Reset filters

Search publications


By keyword
By department

No publications found.

 

Atorvastatin lowers serum calcium levels in lithium-users: results from a randomized controlled trial

Author(s): Soh JF; Bodenstein K; Yu OHY; Linnaranta O; Renaud S; Mahdanian A; Su CL; Mucsi I; Mulsant B; Herrmann N; Rajji T; Beaulieu S; Sekhon H; Rej ...

Background: Although lithium is considered the gold-standard treatment for bipolar disorder (BD), it is associated with a variety of major endocrine and metabolic side effects, including parathyroi ...

Article GUID: 36153583


Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab

Author(s): Chertkow H; Rockwood K; Hogan DB; Phillips N; Montero-Odasso M; Amanullah S; Black S; Bocti C; Borrie M; Feldman H; Freedman M; Hsiung R; Ki ...

Alzheimer's disease is a major cause of morbidity and mortality. Currently, there are no disease-modifying pharmacotherapies for this condition. Aducanumab, an amyloid beta-directed monoclonal ...

Article GUID: 34912492


-   Page 1 / 1   -